Locanabio Raises $100 Million in Series B Financing
Sunday, January 3, 2021
Photo courtesy of Locanabio. Locanabio will pursue gene therapy treatments for severe neurodegenerative and neuromuscular diseases.
San Diego-based Locanabio, a private preclinical-stage biotech company, has raised a $100 million Series B financing to support the advancement of its RNA-targeting gene therapies and expansion of the technology platform...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know